reSee.it - Related Video Feed

The speaker discusses psychedelics and claims that Eli Lilly and Peter Thiel are buying up psychedelic companies. The speaker connects this to an earlier talk asserting that Amanita can “break all addictions” to drugs such as fentanyl, heroin, cocaine, and alcohol. They say the reason Eli Lilly and Peter Thiel would become involved in psychedelics is that, according to the speaker, Amanita mushroom can break the “whole system” that the speaker describes as trying to poison people and keep them addicted to painkillers and opiates. The speaker claims psychedelics can break people from this system and that psychedelics “use subconscious programming” to keep addiction in place, while psychedelics disrupt it. They specifically state that Amanita is presented as the substance that breaks this pattern. The speaker also says they “just saw” Peter Thiel and Eli Lilly, adding that Eli Lilly is described as one of the oldest vaccine companies in the world, “since about the 1600s,” and that they have been producing “garbage.” The speaker then asks why Eli Lilly would be involved and claims that “people can take a couple pills” and then “what can happen next.”

The transcript presents a claim that the most powerful people in the world are targeting individuals using four specific weapons, and that the impact extends beyond the body. The speaker frames this as a deliberate, coordinated effort rather than incidental harm, and emphasizes that the targeting is pervasive and systemic. The central claim is that a movement driven by big corporations seeks to "take the soul away from people, to disconnect people from the higher world," and that to achieve this, there must be an effort to destroy the pineal gland. The speaker states that this palm of a threat has been studied, and argues that the pineal gland is the most sensitive part of the central nervous system, being "highly, highly, highly sensitive to four things." Those four things are identified as Aluminum, glyphosate, fluoride, and WiFi. The implication is that exposure to these four factors makes the pineal gland particularly vulnerable, thus enabling the alleged targeting. In the speaker’s view, the United States stands out as "the only country in the world" that has pushed these four elements into everyday life for people growing up over the past sixty years or so. This claim supports a broader narrative of deliberate manipulation through everyday environmental factors, rather than isolated incidents or ordinary risk. A further element posits that the targeting is the product of a coordinated protocol designed by an "ultra intelligence group of scientists." According to this claim, the protocol involves several interlocking components: fluoridating the drinking water, introducing "nano nylon aluminum" into the air, placing glyphosate in the food supply, and then activating these interventions by "spark it with the right frequencies." The language suggests a planned, technical system intended to exert control or influence through these mechanisms, rather than random exposure or casual policy choices. Taken together, the speaker’s assertions describe a comprehensive scheme in which four substances and a specific environmental technology are alleged to converge on the pineal gland, with the aim of eroding spiritual or higher-order experiences and influencing a broad population through a long-running, covert program orchestrated by powerful interests.

Psychedelics were not made illegal due to safety concerns, but rather because they allow communication with other realities that those in power want to suppress. Imperial College in London is conducting a fascinating study on DMT, mapping this parallel world. Multiple individuals have reported similar experiences and messages from this realm. This may be the hidden reason behind the illegalization of psychedelics.

The speaker claims that marijuana (“Mary Jane”) is owned by Monsanto and that Monsanto works with aluminum companies to spray marijuana with a lot of aluminum. They say that when people smoke it, the aluminum goes into the brain, leading to dementia, brain fog, and other health issues. The speaker also claims that marijuana has been “tweaked,” so people are no longer getting the original cannabis plant, saying Monsanto would not provide the original healing plant of cannabis and instead provides a changed plant with chemicals. The speaker argues the government legalized marijuana for two reasons: to generate large tax revenue and to poison people. They say legalization was not driven by people wanting to smoke marijuana again, but by those underlying motives. The speaker adds that people are driving around “stoned out of their mind,” which they describe as control. They suggest other plants—mugwort, blue lotus, and “amarita,” described as “the Super Mario mushroom”—as alternatives. They claim the government would never give these options to people because they would “break all their addictions.” The speaker concludes that the government needs “vices” as part of a control mechanism, using “same old tactics.”

Tucker Carlson interviews Dr. Daniel Amen about cannabis, brain health, and broader public health trends. Amen cites his 1000-person marijuana study showing lower brain blood flow and activity across all examined regions in users compared with healthy controls, with measurable deficits on SPECT imaging that assess blood flow and mitochondrial function. He explains mitochondria as cellular energy producers and notes that 49% of the tracer in their imaging is taken up by brain mitochondria; thus, low activity on the scan reflects reduced mitochondrial function and blood flow. He also references a separate study from an independent group of 1000 young marijuana users showing reduced blood flow and activity in brain areas involved in learning and memory, aligning with his assertion that marijuana is not innocuous for the brain. Amen lists consequences associated with reduced mitochondrial activity and blood flow: tiredness, low motivation, depression, increased anxiety (due to brain not settling), and, in vulnerable individuals, an increased risk of psychosis. He emphasizes that the connection between heavy marijuana use and psychosis is real and notes a genetic factor: a certain gene abnormality can lead to a sevenfold increase in the risk of psychosis in heavy users, with the general risk estimated at two to four times higher, particularly when use begins in youth. He argues that younger users face more brain development disruption and cites CDC data showing alarming mental-health trends among teens, including 57% of teenage girls reporting persistent sadness, 32% having thought of suicide, 24% having planned to kill themselves, and 13% having attempted it. He suggests marijuana contributes to this “mental mess,” though he acknowledges multiple factors. Carlson pushes back on the view of cannabis as a medicine, prompting Amen to discuss how, while cannabis can help certain conditions (glaucoma, appetite stimulation), it is not universally beneficial and can increase anxiety in some users. Amen describes a “doom loop” in which pain and distress trigger automatic negative thoughts (ANTs), amplifying suffering and potentially leading to relapse or worse mental health outcomes. He argues that cannabis can blunt certain pain pathways but, when used chronically, reinforces dependence and prevents brain rehabilitation. Amen contrasts marijuana with alcohol, describing rumors of “alcohol as health food” as a societal lie, noting recent statements by the American Cancer Society against any alcohol use due to cancer risk. He recounts experiences in psychiatry since the 1980s involving changes in attitudes toward gaming, alcohol, and drug policy, arguing that stimulants and sedatives (opiates, benzodiazepines) have historically created poor outcomes. He claims marijuana industry marketing aims to minimize perceived risk and accuses the industry of funding campaigns to mislead the public, similar to tactics used by historical industry players. In discussing brain imaging, Amen highlights the cerebellum (the “little brain”) as crucial for both movement and cognitive processing. Marijuana’s effect on the cerebellum can slow thinking and impair coordination, which underpins the admonition not to drive high. He explains that cannabis acts on CB1 receptors and modulates dopamine, producing a high but potentially disrupting dopamine in vulnerable individuals, sometimes triggering psychosis. Amen stresses the need to love and protect the brain, arguing that brain health should be prioritized in public policy. He advocates for preventing brain injury, reducing toxin exposure, maintaining sleep, exercise, and a healthy diet, and he introduces the Bright Minds framework: B = Blood flow; R = Retirement and aging (learn new things); I = Inflammation; G = Genetics; H = Head trauma; T = Toxins; M = Materials (personal products); I = Immunity; N = Neurohormones; D = Diabetes; S = Sleep. He explains how each factor affects brain health and how marijuana and obesity harm the brain by decreasing blood flow and increasing inflammation. He cites a study from the University of Pittsburgh showing overweight individuals have smaller brain volumes and older-appearing brains; obese individuals show even greater reductions. He notes that marijuana use lowers testosterone and can contribute to vascular problems, including a reported 600% increased heart attack risk for those over 50 who use marijuana. On ADHD and youth, Amen describes using brain scans to differentiate toxic brains from those with genuine ADHD, emphasizing that stimulants are not the universal answer and that underlying toxicities must be addressed. He recounts a case where a child’s left temporal lobe cyst caused behavioral changes, which surgery ultimately improved after imaging revealed the physical cause. He argues for looking at brain pathology before labeling and treating, and he describes his broader mission to foster a national brain health revolution, encouraging people to ask whether their actions are good for their brain. Amen also discusses psilocybin, kratom, and other substances, acknowledging potential therapeutic uses in specific contexts (psilocybin for PTSD/depression) while warning about risks such as unbalancing effects and the lack of standardized dosing in many studies. He notes a rising trend in mushroom use among youth and increasing emergency-room visits for psilocybin-induced psychosis. He cautions about the lack of regulation for kratom and its potential to worsen brain function, presenting it as another “weapon of mass destruction” in public health discussions. Towards the end, Amen describes his clinical experiences with trauma, epigenetics, and intergenerational influences on mental health, stressing that thoughts, even disturbing ones, do not define character and can be managed through cognitive strategies such as cognitive behavioral techniques and reframing. He closes with a personal call to care for brain health, emphasizing practical steps like sleep, exercise, nutrition, vitamin D optimization, dental health, reducing toxin exposure, and mindful use of technology, including cautions about AI’s potential impact on cognitive function.